Tetanus Toxoid Dose for Newborn Baby
Newborn infants do not receive tetanus toxoid vaccine directly—they rely entirely on passive immunity from maternal antibodies transferred during pregnancy and through colostrum. 1, 2
Maternal Vaccination Strategy (Not Direct Newborn Vaccination)
The protection of newborns against tetanus is achieved through maternal immunization during pregnancy, not by vaccinating the newborn itself. Here's the evidence-based approach:
For Pregnant Women (To Protect Newborns)
Pregnant women should receive Tdap vaccine during the third trimester (ideally 27-36 weeks gestation) of each pregnancy to provide passive immunity to the newborn. 3 The dose is 0.5 mL administered intramuscularly, preferably in the deltoid muscle. 1
- If the mother has completed her childhood vaccination series and was last vaccinated >10 years ago, she needs a booster dose of tetanus toxoid-containing vaccine to prevent neonatal tetanus 3
- If the mother is unvaccinated, she requires at least 2 properly spaced doses during pregnancy, with at least one being Tdap 3
- Timing matters: A tetanus toxoid dose administered ≥28 weeks of gestation correlates with adequate protective antibody levels in newborns 2
When Infants Begin Their Own Vaccination
Infants begin their own tetanus vaccination series at 6 weeks to 2 months of age (not at birth) with DTaP vaccine. 4
The standard schedule is:
- Dose: 0.5 mL intramuscularly 4, 1
- Site: Anterolateral aspect of the thigh for infants and children through age 2 years 1
- Schedule: Doses at 2,4, and 6 months of age, with a fourth dose at 15-18 months 4, 5, 4
Critical Caveats
There is no tetanus toxoid vaccine given to newborns at birth. The hepatitis B vaccine is the only vaccine routinely given at birth. 5, 6 Any attempt to give tetanus toxoid directly to a newborn would be:
- Off-label and inappropriate
- Potentially harmful
- Unnecessary if maternal immunity is adequate
Passive immunity from vaccinated mothers provides protection for approximately 3-6 months after birth, bridging the gap until the infant can begin their own vaccination series. 2, 7 This requires that the newborn achieves adequate colostral IgG transfer (>800 mg/dL or 8 g/L). 7
Special Circumstances
If a newborn is born to an unvaccinated mother and experiences a high-risk event (such as umbilical infection or contaminated delivery), only passive immunization with Tetanus Immune Globulin (TIG) should be considered—not active vaccination with tetanus toxoid, as the infant cannot mount an adequate immune response at this age. 8